Paper Details
- Home
- Paper Details
Intervention Stigma toward Medications for Opioid Use Disorder: A Systematic Review.
Author: LightTimothy, MaddenErin Fanning, PrevedelSuzanne, SulzerSandra H
Original Abstract of the Article :
Medications for opioid use disorder (MOUD) are evidence-based treatments, yet can be controversial among some populations. This study provides a systematic review of prejudice and discrimination toward MOUD, a form of "intervention stigma," or stigma associated with a particular medical treatment. A...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1080/10826084.2021.1975749
データ提供:米国国立医学図書館(NLM)
Intervention Stigma: A Barrier to Opioid Use Disorder Treatment
Medications for opioid use disorder (MOUD) represent a vital tool in combating the opioid epidemic, offering evidence-based treatment options for individuals struggling with addiction. However, these treatments often face significant stigma, hindering access to care and perpetuating the cycle of addiction. This research delves into the complex issue of intervention stigma, examining the prejudice and discrimination directed towards MOUD.
The study conducted a systematic review of literature published between 1998 and 2018, analyzing studies that empirically examined stigma towards MOUD. The findings revealed a pervasive pattern of stigma, evident among healthcare providers, peer patients, and the general public. The stigma was often rooted in a lack of understanding, a preference for abstinence-based treatment, and a perception of MOUD as being equivalent to illicit substance use. These findings highlight the need to address the root causes of intervention stigma and promote greater awareness and understanding of MOUD.
Breaking Down Barriers: Towards Inclusive and Equitable Care
This study underscores the urgent need to address the stigma associated with MOUD, a crucial step towards promoting access to evidence-based treatment for individuals struggling with opioid use disorder. The findings highlight the importance of educational initiatives to combat misinformation and promote understanding of MOUD, as well as policies that address the regulatory challenges associated with methadone treatment. By promoting inclusivity and reducing stigma, we can create a more supportive environment for individuals seeking treatment and pave the way for a more equitable and effective approach to combating opioid addiction.
Dr. Camel's Conclusion
The stigma surrounding MOUD represents a significant barrier to effective treatment for opioid use disorder. This study provides valuable insights into the nature and sources of this stigma, offering a roadmap for developing strategies to combat it. The fight against opioid addiction requires a multifaceted approach that includes addressing the stigma associated with treatment. As a researcher, I am dedicated to promoting understanding, reducing stigma, and advocating for access to evidence-based care for individuals struggling with addiction. We must strive to create a world where those seeking help receive compassionate and effective treatment, free from the judgment and discrimination that can hinder their recovery.
Date :
- Date Completed 2022-03-08
- Date Revised 2022-03-08
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.